The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington’s Disease Mice

Lignende værker

• Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease
  af: Jia, Haiqun, et al.
  Udgivet: (2012)
• Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin–proteasomal and autophagy systems
  af: Jia, Haiqun, et al.
  Udgivet: (2012)
• HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation
  af: Jia, Haiqun, et al.
  Udgivet: (2015)
• Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs()
  af: Xiao, Yufeng, et al.
  Udgivet: (2020)
• Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich's Ataxia: A New Synthetic Route
  af: Xu, Chunping, et al.
  Udgivet: (2011)